BEAM
Beam Therapeutics Inc
25.70$
+4.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -522.2% | 42.7% | -1,346.1% | -705.1% | -617.6% | -254.0% | -1,390.7% | -903.0% | -840.2% | -73.0% | -404.9% | -13,489.0% | -230.3% | |
| 30.2% | 1.7% | 73.3% | 47.4% | 38.4% | 50.3% | 74.0% | 65.4% | 57.3% | 5.0% | 17.7% | 1,104.1% | 14.3% | |
| 150.3% | 7.2% | 395.2% | 268.5% | 207.2% | 100.5% | 357.2% | 287.8% | 234.6% | -64.7% | 60.0% | 3,934.3% | -8.2% | |
| -114.2% | -10.0% | -512.3% | -220.1% | -179.4% | -69.0% | -341.0% | 40.6% | -73.5% | -89.3% | -175.2% | 5,272.7% | -88.9% | |
| 46.2% | 1.1% | 32.9% | 16.7% | 11.1% | 9.9% | 41.0% | 37.0% | 51.7% | 3.3% | 7.0% | 492.7% | 8.6% | |
| -59.5% | 31.0% | -721.5% | 743.2% | 173.1% | 420.0% | -1,674.6% | -2,012.9% | 677.0% | 95.0% | 79.6% | -2,015.3% | 121.4% | |
| – | – | – | – | -1.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 295.8% | 0.0% | 60.2% | |
| 213.9% | 10.7% | 39.1% | 1.1% | 8.8% | 11.5% | 6,337.1% | 13.1% | 17.3% | 1.7% | 304.4% | 1,535.3% | 69.0% | |
| -367.8% | 84.4% | -2,028.5% | 39.2% | -435.7% | 177.5% | 3,271.8% | -2,902.8% | -146.1% | 23.7% | -21.0% | -13,969.0% | -39.9% | |
| -568.4% | 41.6% | -1,379.0% | -721.8% | -628.6% | -263.9% | -1,431.7% | -940.1% | -891.8% | -76.3% | -412.0% | -13,981.6% | -238.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.